List of insiders holdings for Histogen Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ADVENT VENTURE PARTNERS LLP 10% Owner |
2014-02-13 14:01:02 | 2,243,503 0 |
2,243,503 | Form 13G |
2 | Perret Marc Olivier Director 10% Owner |
2013-08-01 19:18:10 | 30,000 1,504,062 |
1,534,062 | Form 4 |
3 | COOPERATIVE GILDE HEALTHCARE II U.A. 10% Owner |
2013-08-01 19:10:35 | 1,504,062 0 |
1,504,062 | Form 4 |
4 | KLINGENSTEIN PAUL H Director |
2014-02-25 17:37:58 | 40,644 1,404,535 |
1,445,179 | Form 4 |
5 | EVNIN LUKE Foley Todd GADICKE ANSBERT KAILIAN VAUGHN M Vander Vort John 10% Owner |
2013-08-01 14:19:53 | 0 1,241,016 |
1,241,016 | Form 4 |
6 | Mento Steven J President and CEO |
2023-03-14 16:32:12 | 213,587 0 |
213,587 | Form 4 |
7 | Hagerty David T EVP, Clinical Development |
2019-02-11 16:15:20 | 175,000 0 |
175,000 | Form 4 |
8 | Latterich Martin SVP, Technical Operations |
2022-02-22 18:18:41 | 134,900 0 |
134,900 | Form 4 |
9 | RIPLEY DANIEL L. SVP, Bus Dev, P&A Mgmt |
2019-02-11 16:19:31 | 100,000 32,431 |
132,431 | Form 4 |
10 | Smith Edward F III SVP, Reg Affairs and QA |
2019-02-11 16:20:30 | 110,875 0 |
110,875 | Form 4 |
11 | Knudson Susan A. COO and CFO |
2023-03-14 16:33:04 | 106,793 0 |
106,793 | Form 4 |
12 | Spada Alfred P. See Remarks |
2023-02-27 16:18:17 | 106,793 0 |
106,793 | Form 4 |
13 | Daniels Moya See Remarks |
2021-01-15 16:11:52 | 100,000 0 |
100,000 | Form 4 |
14 | Naughton Gail K See Remarks |
2021-01-15 16:14:23 | 95,000 0 |
95,000 | Form 4 |
15 | VANDERTIE MICHELLE L Vice President, Finance |
2019-08-01 16:13:44 | 86,375 0 |
86,375 | Form 4 |
16 | Reyes Joyce See Remarks |
2023-04-28 18:56:26 | 64,076 0 |
64,076 | Form 4/A |
17 | Cashion Charles SVP, Finance, CFO and Sec. |
2017-02-01 16:21:33 | 57,500 0 |
57,500 | Form 4 |
18 | BURGESS GARY C. Sr. VP, Clin. Res. & CMO |
2014-02-11 16:49:51 | 50,000 0 |
50,000 | Form 4 |
19 | HALE DAVID F Director |
2019-07-01 16:31:01 | 45,000 0 |
45,000 | Form 4 |
20 | Pascoe Richard W President, CEO & Director |
2021-03-30 18:28:01 | 30,000 0 |
30,000 | Form 4 |
21 | Scott Kathleen D. Director |
2019-11-19 16:10:50 | 30,000 0 |
30,000 | Form 4 |
22 | Klassen Preston Director |
2019-07-01 16:33:36 | 20,000 0 |
20,000 | Form 4 |
23 | Malik Shahzad Director 10% Owner |
2016-06-27 16:23:40 | 20,000 0 |
20,000 | Form 4 |
24 | Zhang Yizhuo Director |
2020-10-09 16:15:57 | 20,000 0 |
20,000 | Form 4 |
25 | Chang Stephen Director |
2020-10-09 16:05:33 | 20,000 0 |
20,000 | Form 4 |
26 | Scopa James Paul Director |
2018-06-25 16:07:41 | 20,000 0 |
20,000 | Form 4 |
27 | Van Wart Harold Director |
2019-07-01 16:34:48 | 20,000 0 |
20,000 | Form 4 |
28 | LARUE WILLIAM R Director |
2019-07-01 16:34:13 | 20,000 0 |
20,000 | Form 4 |
29 | Marshall Keith W EVP, COO & CFO |
2020-05-27 06:09:23 | 19,885 0 |
19,885 | Form 4 |
30 | LACASSE LOUIS P Director |
2015-06-15 16:09:34 | 15,000 0 |
15,000 | Form 4 |
31 | Crean David Hugh Director |
2023-06-21 16:07:29 | 6,835 0 |
6,835 | Form 4 |
32 | Fuhrmann Rochelle Director |
2023-06-21 16:08:04 | 6,835 0 |
6,835 | Form 4 |
33 | Jackson Jonathan Director |
2023-06-21 16:08:39 | 6,835 0 |
6,835 | Form 4 |
34 | KISNER DANIEL L Director |
2023-06-21 16:09:19 | 6,835 0 |
6,835 | Form 4 |
35 | Satz Brian Director |
2023-06-21 16:10:02 | 6,835 0 |
6,835 | Form 4 |
36 | Windham-Bannister Susan Richards Director |
2023-06-21 16:11:05 | 6,835 0 |
6,835 | Form 4 |
37 | Aberdare GP III L.L.C. Aberdare Ventures III LP Aberdare Partners III LP Former 10% Owner |
2017-02-13 06:05:32 | 5,251 0 |
5,251 | Form 13G |
38 | MPM BioVentures IV QP LP MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BIOVENTURES V GP LLC MPM BIOVENTURES V LLC MPM BIOVENTURES V L.P. MPM ASSET MANAGEMENT INVESTORS BV5 LLC 10% Owner |
2020-02-05 14:11:03 | 0 0 |
0 | Form 13G |